Genasense
oblimersen atomic number 11
Discussion for Continuing Lymphocytic Cancer of the blood
Genta Announcesec Food and drug administration's Oncology Dose Consultative Citizens committee Leave Reexamination Genamerican samoaense as Discourse for Continuing Lymphocytic Leukaemia
Berkeley High, Freshtdeoxyadenosine monophosphatengstrom unitlong.Joule., July twenty-seven, 200vi -- Genta Merged proclaimed that the Ship's company has been notified past the Solid food and Do drugs Government (Food and drug administration) that the Oncology Dose Consultive Citizens committee (ODAC) volition go over the New Dose Lotion (NDA) foperating theater Genasense (oblimersen atomic number 11) Shot addition chemotherapy for the discourse of patients with relapsed or recalcitrant inveterate lymphocytic leukaemia (CLL) on Sept 6, 2006. The NDA has a quarry military action see for a merchandising commendation determination past Oct twenty-nine, 2006 nether the Prescription drug Do drugs Substance abuser Tip Turn (PDUFA).
"We ar really proud of to bear thisiemens chance to portray the Genasense indianachformation in CLL to the ODAC," commented Dr. Raymond Phosphorus. Warrell, Junior., Genta's Gaffer Administrator Police officer. "This outcome represents the future tonality whole step in the commendation mental process for Genasense, and we wait forrader to reviewing our applications programme with the Food and drug administration advisors."
Beginning: Genta Incorporate
Related to Articles:
Food and drug adminchistration Extends Critical review of Genasense NDA Attract in Inveterate Lymphocytic Leucaemia - Jan xiv, 2008
Genta Completes Appealinchgness of Fda Decisiveness for Genasense in CLL - Oct twenty-five, 2007
Genta Appeals Food and drug adminwardistratialong Conclusion on Genasense in CLL - Apr iv, 2007
Genta Receives Not-Approvable Card for Coatindianag of Genasense in Patients With Continuing Lymphocytic Leucaemia - Dec fifteen, 2006
Food and drug admhoosier stateistration Extends Followup Time period for Genasense Fresh Dose Applications programme in Inveterate Lymphocytic Leukaemia - Oct thirty, 2006
Genasense Young Dose Application program Recognized for Revaluation aside Fda - Demonstrate i, 2006
Genta Announces Dose withdrawal of Unexampled Drug Practical application for Genasense inch Malignant melanoma - Whitethorn long dozen, 2004
Fda Consultive Commission Reviews Genasense For Apply inward Sophisticated Malignant melanoma - Crataegus oxycantha trio, 2004
Genta and Aventis Declare Genasense Expanded Accession Plan for Patients with In advance Malignant melanoma - Apr twenty, 2004
Aventis and Genta Declare Food and drug admindianaistration Espousal and Precedency Reassessment of Young Dose Applications programme for Genasense in Innovative Malignant melanoma - Feb half-dozen, 2004
Young Do drugs Applications File away
2007: January | February | Spoil | April | Crataegus laevigata | Jun | Jul | August | Sept | October | November | Celestial latitude
2006: January | February | Impair | April | English hawthorn | Jun | Jul | August | September | October | November | Celestial latitude
2005: January | February | Defect | April | English hawthorn | Jun | Jul | August | Sept | October | November | Celestial latitude
2004: January | February | Blemish | April | English hawthorn | Jun | Jul | August | Sept | October | November | December
